Amprius Technologies (NYSE:AMPX) Director Sells $7,618,412.24 in Stock

Amprius Technologies, Inc. (NYSE:AMPX) Director Wen Hsuan Hsieh sold 413,146 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $18.44, for a total transaction of $7,618,412.24. Following the completion of the sale, the director directly owned 44,444 shares in the company, valued at approximately $819,547.36. This trade represents a 90.29% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Amprius Technologies Price Performance

Shares of AMPX stock traded down $0.36 during mid-day trading on Friday, reaching $17.93. The stock had a trading volume of 8,800,430 shares, compared to its average volume of 9,586,997. Amprius Technologies, Inc. has a 52-week low of $1.80 and a 52-week high of $19.40. The stock’s 50-day moving average price is $11.88 and its two-hundred day moving average price is $11.07.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.03. The company had revenue of $25.23 million for the quarter, compared to the consensus estimate of $22.91 million. Amprius Technologies had a negative return on equity of 24.29% and a negative net margin of 60.30%.Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. As a group, equities analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Institutional Investors Weigh In On Amprius Technologies

Hedge funds have recently made changes to their positions in the company. Alberta Investment Management Corp purchased a new stake in Amprius Technologies in the fourth quarter worth $1,001,000. Vident Advisory LLC purchased a new stake in shares of Amprius Technologies in the 4th quarter worth about $107,000. Summit Securities Group LLC bought a new position in shares of Amprius Technologies in the 4th quarter worth about $54,000. Numerai GP LLC increased its stake in shares of Amprius Technologies by 29.1% in the 4th quarter. Numerai GP LLC now owns 96,209 shares of the company’s stock worth $759,000 after acquiring an additional 21,698 shares in the last quarter. Finally, Osterweis Capital Management Inc. lifted its position in Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company’s stock valued at $3,589,000 after acquiring an additional 267,385 shares during the period. 5.04% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

AMPX has been the subject of a number of research analyst reports. B. Riley Financial raised their price target on Amprius Technologies from $16.00 to $22.00 and gave the stock a “buy” rating in a research note on Monday. Craig Hallum boosted their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Friday, March 6th. Oppenheimer reaffirmed an “outperform” rating and issued a $17.00 target price on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Finally, Roth Mkm reiterated a “buy” rating and set a $20.00 price target (up from $16.00) on shares of Amprius Technologies in a research report on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $19.75.

More Amprius Technologies News

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.